Boundless Bio, Inc. - BOLD Net earnings per share (EPS TTM)

Corporate company logo of Boundless Bio Inc. (BOLD)

The TTM earnings per share illustrates the financial standing of Boundless Bio, Inc. (BOLD), where -2.86 defines the current value of the metric. The business relies on extrachromosomal DNA analysis patents and complex bioinformatics. Efficiency is enhanced through the express delivery of diagnostic systems to laboratories. The company is currently undergoing a long-term investment cycle, focusing on cancer therapy regardless of macroeconomic conditions.

BOLD Boundless Bio, Inc. Net earnings per share for the last four quarters (03/29/2024 - 11/10/2026)

Analytical breakdowns for Boundless Bio Inc. (BOLD)

- current quotes and average value forecast:
Price Chart Boundless Bio, Inc.|BOLD - Price Target Chart
- issuer market value details:
Market Capitalization Boundless Bio, Inc.|BOLD - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Boundless Bio|BOLD - Book Valuation of Business|Market Value to Book Value Ratio boundlessbio.com|BOLD - Company Total Asset Base
- debt and liquidity details:
Total Debt to Equity Ratio Boundless Bio, Inc.|BOLD - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Boundless Bio, Inc|BOLD - Company Debts|Debts to Book Capitalization Boundless Bio, Inc.|BOLD - Long-Term Debt Volume|Company Short-Term Debt Boundless Bio|Quick Liquidity Indicator boundlessbio.com
- earnings and multiples data:
BOLD - Final Profit|Projected Future Earnings Boundless Bio, Inc.|BOLD - Business Payback Period|Future Price to Earnings Boundless Bio|BOLD - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Boundless Bio, Inc.|BOLD - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Boundless Bio|BOLD - Net earnings per share for the last four quarters|Quarterly EPS earnings growth boundlessbio.com|BOLD - Earnings per share growth in current year|Net earnings per share growth forecast for next year Boundless Bio, Inc.
Fundamental company valuation:Boundless Bio, Inc. (BOLD)
Flagship merchandise of Boundless Bio Inc.

Boundless Bio, Inc. (BOLD) develops cutting-edge drugs to combat resistant forms of cancer by targeting extrachromosomal DNA. This indicator digitizes the effectiveness of this strategy by allocating total annual net income per common share. The metric compares the volume of issuance with real fundamental demand during periods of market volatility. It is critical for investors to assess the risk of capital stagnation during a prolonged downturn. Analysis via a rolling 12-month EPS chart allows for the identification of entry points into the asset.

Competitors of Boundless Bio, Inc.

TEM - Earnings per share for the last twelve months|QGEN: Earnings per share for the last twelve months|IONS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Repligen Corp (RGEN)|Earnings per share for the last twelve months Avidity|CRISPR (CRSP) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months GeneDx Holdings Corp. (WGS)|Net earnings per share for the last four quarters ultragenyx.com|Beam Therapeutics - Net earnings per share for the last 12 months|Earnings per share for the trailing year SRPT|Twist Bio - Net earnings per share (EPS TTM)|TXG: Earnings per share for the last twelve months|NTLA: Net earnings per share (EPS TTM)|STOK - Net earnings per share for the last four quarters|Earnings per share for the last twelve months BioLife Solutions|Net earnings per one share for the last twelve months Wave Life Sciences Ltd WVE|Net earnings per share for the last 12 months MAZE (Maze Tx)|SION (Sionna Corp) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PRME (Prime Medicine, Inc.)|Net earnings per share for the last four quarters tayshagtx.com (TSHA)|QURE - Earnings per share for the last twelve months|MGTX (MeiraGTx Holdings) - Earnings per share for the last 12 months|RGNX: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Solid Corp|Net earnings per share for the last 12 months OCGN|pacb.com (PACB) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BNTC|Earnings per share for the last twelve months DSGN (Design Therapeutics Inc)|Earnings per share for the last twelve months Rocket Pharmaceuticals Inc RCKT|4D Molecular Corp (FDMT) - Net earnings per one share for the last twelve months|LXEO - Earnings per share for the last twelve months|KRRO: Earnings per share for the last twelve months|EDIT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months SLN|PRQR (ProQR) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months CDXS (Codexis Bio)|Earnings per share for the last twelve months Sangamo Therapeutics (SGMO)|nautilus.bio - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) MGX (Metagenomi)|Net earnings per share (EPS TTM) Precision BioSciences Inc. DTIL|Generation Bio Corp - Net earnings per share (EPS TTM)|XCUR: Earnings per share for the last twelve months|imunon.com (IMNN) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Phio Pharmaceuticals Corp. (PHIO)|Net earnings per share for the last 12 months MBIO|Net earnings per share (EPS TTM) TransCode|Earnings per share for the last twelve months Bionano Genomics, Inc. (BNGO)|Applied DNA Corp - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) BLUE (bluebird bio, Inc.)|IPA: Earnings per share for the last 12 months|OMGA - Earnings per share for the last twelve months|OMIC: Earnings per share for the last twelve months|RGLS: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Syros Pharmaceuticals, Inc (SYRS)|Earnings per share for the last twelve months Telesis Bio, Inc.|traconpharma.com (TCON) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Unity Biotechnology, Inc. (UBX)